{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T19:33:25Z","timestamp":1781206405830,"version":"3.54.1"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2020,11,12]],"date-time":"2020-11-12T00:00:00Z","timestamp":1605139200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2020,11,12]],"date-time":"2020-11-12T00:00:00Z","timestamp":1605139200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gene Ther"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1038\/s41434-020-00210-0","type":"journal-article","created":{"date-parts":[[2020,11,12]],"date-time":"2020-11-12T16:20:29Z","timestamp":1605198029000},"page":"304-311","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Molecular targeting of vulnerable RNA sequences in SARS CoV-2: identifying clinical feasibility"],"prefix":"10.1038","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8399-1556","authenticated-orcid":false,"given":"G. Ian","family":"Gallicano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John L.","family":"Casey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayu","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samiksha","family":"Mahapatra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,11,12]]},"reference":[{"key":"210_CR1","doi-asserted-by":"publisher","first-page":"S563","DOI":"10.1093\/infdis\/jiy662","volume":"222(Supplement_","author":"T Shi","year":"2020","unstructured":"Shi T, Arnott A, Semogas I, Falsey AR, Openshaw P, Wedzicha JA, et al. The etiological role of common respiratory viruses in acute respiratory infections in older adults: a systematic review and meta-analysis. J Infect Dis. 2020;222(Supplement_7):S563\u20139. https:\/\/doi.org\/10.1093\/infdis\/jiy662.","journal-title":"J Infect Dis"},{"key":"210_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-1-4939-2438-7_1","volume":"1282","author":"AR Fehr","year":"2015","unstructured":"Fehr AR, Perlman S. Coronaviruses: an overview of their replication and pathogenesis. Methods Mol Biol. 2015;1282:1\u201323.","journal-title":"Methods Mol Biol"},{"key":"210_CR3","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.mod.2018.02.002","volume":"150","author":"Z Zhang","year":"2018","unstructured":"Zhang Z, Ursin R, Mahapatra S, Gallicano GI. CRISPR\/CAS9 ablation of individual miRNAs from a miRNA family reveals their individual efficacies for regulating cardiac differentiation. Mech Dev. 2018;150:10\u201320.","journal-title":"Mech Dev"},{"key":"210_CR4","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/j.molcel.2009.08.020","volume":"35","author":"A Lal","year":"2009","unstructured":"Lal A, Navarro F, Maher CA, Maliszewski LE, Yan N, O\u2019Day E, et al. miR-24 Inhibits cell proliferation by targeting E2F2, MYC, and other cell-cycle genes via binding to \u201cseedless\u201d 3\u2019UTR microRNA recognition elements. Mol Cell. 2009;35:610\u201325.","journal-title":"Mol Cell"},{"key":"210_CR5","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1089\/scd.2014.0051","volume":"24","author":"SM Larabee","year":"2015","unstructured":"Larabee SM, Coia H, Jones S, Cheung E, Gallicano GI. miRNA-17 members that target Bmpr2 influence signaling mechanisms important for embryonic stem cell differentiation in vitro and gastrulation in embryos. Stem Cells Dev. 2015;24:354\u201371.","journal-title":"Stem Cells Dev"},{"key":"210_CR6","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/j.cell.2008.02.019","volume":"132","author":"A Ventura","year":"2008","unstructured":"Ventura A, Young AG, Winslow MM, Lintault L, Meissner A, Erkeland SJ, et al. Targeted deletion reveals essential and overlapping functions of the miR-17 through 92 family of miRNA clusters. Cell. 2008;132:875\u201386.","journal-title":"Cell"},{"key":"210_CR7","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1089\/scd.2011.0350","volume":"21","author":"J Wang","year":"2012","unstructured":"Wang J, Cao N, Yuan M, Cui H, Tang Y, Qin L, et al. MicroRNA-125b\/Lin28 pathway contributes to the mesendodermal fate decision of embryonic stem cells. Stem Cells Dev. 2012;21:1524\u201337.","journal-title":"Stem Cells Dev"},{"key":"210_CR8","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1038\/bjc.2012.587","volume":"108","author":"W Wu","year":"2013","unstructured":"Wu W, Takanashi M, Borjigin N, Ohno SI, Fujita K, Hoshino S, et al. MicroRNA-18a modulates STAT3 activity through negative regulation of PIAS3 during gastric adenocarcinogenesis. Br J Cancer. 2013;108:653\u201361.","journal-title":"Br J Cancer"},{"key":"210_CR9","doi-asserted-by":"publisher","first-page":"e87780","DOI":"10.1371\/journal.pone.0087780","volume":"9","author":"W Zhu","year":"2014","unstructured":"Zhu W, He J, Chen D, Zhang B, Xu L, Ma H, et al. Expression of miR-29c, miR-93, and miR-429 as potential biomarkers for detection of early stage non-small lung cancer. PLoS ONE. 2014;9:e87780. https:\/\/doi.org\/10.1371\/journal.pone.0087780.","journal-title":"PLoS ONE"},{"key":"210_CR10","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.omtn.2017.04.011","volume":"7","author":"EL Pfister","year":"2017","unstructured":"Pfister EL, Chase KO, Sun H, Kennington LA, Conroy F, Johnson E, et al. Safe and efficient silencing with a Pol II, but Not a Pol lII, promoter expressing an artificial miRNA targeting human huntingtin. Mol Ther Nucleic Acids. 2017;7:324\u201334.","journal-title":"Mol Ther Nucleic Acids"},{"key":"210_CR11","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/nrd.2016.246","volume":"16","author":"R Rupaimoole","year":"2017","unstructured":"Rupaimoole R, Slack FJ. MicroRNA therapeutics: towards a new era for the management of cancer and other diseases. Nat Rev Drug Discov. 2017;16:203\u201322.","journal-title":"Nat Rev Drug Discov"},{"key":"210_CR12","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1172\/JCI84424","volume":"127","author":"BD Adams","year":"2017","unstructured":"Adams BD, Parsons C, Walker L, Zhang WC, Slack FJ. Targeting noncoding RNAs in disease. J Clin Invest. 2017;127:761\u201371.","journal-title":"J Clin Invest"},{"key":"210_CR13","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1038\/nrd.2016.117","volume":"16","author":"M Matsui","year":"2017","unstructured":"Matsui M, Corey DR. Non-coding RNAs as drug targets. Nat Rev Drug Discov. 2017;16:167\u201379.","journal-title":"Nat Rev Drug Discov"},{"key":"210_CR14","first-page":"528","volume":"19","author":"S Ghosh","year":"2020","unstructured":"Ghosh S, Firdous SM, Nath A. siRNA could be a potential therapy for Covid-19. EXCLI J. 2020;19:528\u201331.","journal-title":"EXCLI J"},{"key":"210_CR15","doi-asserted-by":"publisher","first-page":"264","DOI":"10.2174\/157488807782793781","volume":"2","author":"KM Foshay","year":"2007","unstructured":"Foshay KM, Gallicano GI. Small RNAs, big potential: the role of MicroRNAs in stem cell function. Curr Stem Cell Res Ther. 2007;2:264\u201371.","journal-title":"Curr Stem Cell Res Ther"},{"key":"210_CR16","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.ydbio.2008.11.016","volume":"326","author":"KM Foshay","year":"2009","unstructured":"Foshay KM, Gallicano GI. miR-17 family miRNAs are expressed during early mammalian development and regulate stem cell differentiation. Dev Biol. 2009;326:431\u201343.","journal-title":"Dev Biol"},{"key":"210_CR17","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1080\/15384101.2015.1026519.","volume":"14","author":"S Badodi","year":"2015","unstructured":"Badodi S, Baruffaldi F, Ganassi M, Battini R, Molinari S. Phosphorylation-dependent degradation of MEF2C contributes to regulate G2\/M transition. Cell Cycle. 2015;14:1517\u201328. https:\/\/doi.org\/10.1080\/15384101.2015.1026519.","journal-title":"Cell Cycle"},{"key":"210_CR18","doi-asserted-by":"crossref","unstructured":"Ou X, Liu Y, Lei X, Li P, Mi D, Ren L, et al. Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV. Nat Commun. 2020;11.","DOI":"10.1038\/s41467-020-15562-9"}],"container-title":["Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41434-020-00210-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41434-020-00210-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41434-020-00210-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T02:47:09Z","timestamp":1744166829000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41434-020-00210-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,12]]},"references-count":18,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["210"],"URL":"https:\/\/doi.org\/10.1038\/s41434-020-00210-0","relation":{},"ISSN":["0969-7128","1476-5462"],"issn-type":[{"value":"0969-7128","type":"print"},{"value":"1476-5462","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,12]]},"assertion":[{"value":"14 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}